Renalytix plc (NASDAQ: RNLX)
$0.34
+0.0092 ( +2.79% ) 1.5M
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
Market Data
Open
$0.34
Previous close
$0.33
Volume
1.5M
Market cap
$26.54M
Day range
$0.28 - $0.35
52 week range
$0.22 - $3.66
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Nov 14, 2023 |
10-q | Quarterly Reports | 77 | Nov 14, 2023 |
def | Proxies and info statements | 9 | Nov 13, 2023 |
pre | Proxies and info statements | 9 | Nov 03, 2023 |
8-k | 8K-related | 15 | Oct 31, 2023 |
8-k | 8K-related | 13 | Oct 24, 2023 |
8-k | 8K-related | 15 | Oct 17, 2023 |
10-k/a | Quarterly Reports | 17 | Oct 06, 2023 |
8-k | 8K-related | 13 | Oct 03, 2023 |
10-k | Annual reports | 102 | Sep 28, 2023 |